Liver Transplantation

Article	Citations
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	53
Issue Information ‐ Instructions to Authors	48
Deceased donor selection and management	44
Issue Information ‐ Author Checklist	44
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	43
Robotic liver transplantation: University of modena experience	40
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	38
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	38
Issue Information	37
Introducing the Certificate of Added Qualification (CAQ) Corner	35
Issue Information	34
Issue Information ‐ Instructions to Authors	34
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	33
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	33
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	32
Machine learning improves post-transplantation hepatocellular carcinoma recurrence prediction	32
Semaglutide is effective in achieving weight loss in liver transplant recipients	32
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	31
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	31
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	29
Acute liver failure: Do we have a consensus regarding management?	29
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	28
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	28
Making the best use of testing for blood phosphatidylethanol	27
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	26

Racial and ethnic disparities in extended criteria allograft use for liver transplantation	26
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	26
Three problems, 2 viruses, and 1 man with a vision and voice: Larry Kramer, medical activist	26
Incidence and risk factors for chronic rejection in pediatric liver transplantation	25
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	25
Issue Information ‐ Author Checklist	25
Issue Information	24
Issue Information	24
Erratum	24
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	23
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	23
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	23
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	23
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	23
Remembrance of a Passing Pandemic	21
Issue Information ‐ Author Checklist	21
PRO: Is the management of ACLF better in a liver-dedicated ICU?	21
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	21
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	21
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	20
PRO: All patients should receive a palliative care consult during LT evaluation	20
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	19
Policy Corner: HCC exception update	19
Bariatric surgery post-liver transplantation: A Belgian nationwide study	19
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	19
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	19
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	19
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	19
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	19
When worlds collide	19
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	19
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	18
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	18
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis	18
Operational tolerance is not always permanent	18
Those Donor Leucocytes Again? This Time It’s VITT!	18
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	18
Liver transplantation for pediatric liver malignancies	18
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	18
Issue Information	17
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	17
Issue Information ‐ Author Checklist	17
Issue Information ‐ Instructions to Authors	17
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	17
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	17
Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	16
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	16
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand	16
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	16
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	16

Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	16
Cannabis and liver transplant: We need to chill, man	15
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	15
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	15
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	15
Decompensated cirrhosis but low MELD – should we wait or refer for liver transplantation?	15
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	15
Navigating the road to liver transplantation equity	15
Priority for kidney after liver transplantation: A safety net for all?	15
Reply: ChatGPT and unknown clinical questions about liver transplantation	15
	15
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	15
A new tool to predict future liver allograft dysfunction?	15
Issue Information	15
Looking for literal improvement in liver transplant outcomes	14
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	14
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	14
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	14
Outcomes using steatotic liver grafts: Will machines score the final goal?	14
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	13
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	13
Long‐term quality of life of living liver donors: A Japanese nationwide survey	13
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	13
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	13
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	13
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	13
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	13
Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?	13
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	12
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay	12
No Salvation Without Regeneration	12
Issue Information	12
Issue Information	12
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	12
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	12
A New Hope for a New Year	12
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	11
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure	11
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	11
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	11
Bacterascites confers poor patient prognosis beyond MELD prediction	11
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	11
Management of portal vein thrombosis in liver transplant candidates	11
Blood Pressure Variability Early After Liver Transplantation Predicts Long‐Term Mortality	11
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	11
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis	11
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	11
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	11
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	11
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	11
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	11
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	11
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	10
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	10
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	10
Policy Corner: Polycystic liver disease MELD exception update	10
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	10
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	10
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	10
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	9
Issue Information	9
Reply	9
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	9
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	9
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	9
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	9
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma	9
No transplant candidate left behind	9
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	9
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	9
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?	9
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	9
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	9
Informatics-driven solutions for optimal care delivery in liver transplantation	9
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	9
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	8
Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
Erratum	8
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	8

Issue Information ‐ Instructions to Authors	8
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	8
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	8
Erratum	8
Reduced Discard Rates of Split Liver Grafts by Having a Combined Adult‐Pediatric LT Program	8
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	8
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	8
Financial burden of cirrhosis is significantly reduced after liver transplantation	8
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	8
Language Accessibility of Liver Transplantation Center Websites	8
Issue Information ‐ Instructions to Authors	8
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	8
Speaking of the (Barely Legal) Elephant in the Room: Herbal or Dietary Supplement–Related Acute Liver Failure	8
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	7
Measuring the Toll of Acute Illness–Derived Frailty in Decompensated Cirrhosis	7
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	7
Policy Corner: Cholangitis exception update	7
Second thoughts about second opinions for liver transplantation	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis	7
Portopulmonary hypertension: May we agree to disagree?	7
Geospatial analysis of liver donation after death by drug intoxication	7
Does hepatectomy technique matter?	7
Reply	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	7
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	7
Offer Acceptance Patterns for Liver Donors Aged 70 and Older	7
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	7
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	7
Fellows’ Corner	7
Untangling the web of waitlist dropout in HCC	7
Reduction of hepatectomy times in Dutch organ procurement teams	7
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	7
Barriers to liver transplant referral in safety net settings: A national provider survey	7
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	6
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	6
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	6
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	6
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	6
Issue Information	6
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	6
Anonymous Nondirected Living Liver Donation: Has the Time Come to Formalize the Process?	6
Maximizing outcomes by donor-recipient age matching in liver transplantation	6
Anonymity: What does it mean and why is it important to anonymous living liver donors?	6
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	6
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	6
Quantitative methods for optimizing patient outcomes in liver transplantation	6
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	6
Issue Information ‐ Instructions to Authors	6
Erratum	6
“Winning the peace” against obesity in recipients of liver transplant	6
Creation of a new VA liver transplantation center increased access and retained care within veterans health administration	6
Telemedicine in Hepatology: Current Applications and Future Directions	6
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	6
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	6
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	5
Efficiency of machine perfusion in pediatric liver transplantation	5
Use of Livers With Fibrosis Based on Donor Hospital Biopsy: Missed Opportunities?	5
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	5
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	5
Proposing a Framework to Assess the Methodological Quality of Prognostic Models	5
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	5
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Statement of Ownership	5
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	5
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	5
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	5
Issue Information ‐ Author Checklist	5
Issue Information ‐ Author Checklist	5
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	5
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	5
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	5
	5
	5
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	5
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	5
Long‐term follow‐up of living liver donors	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
Issue Information	5
Salvaging the fatty liver for transplant: is short duration NMP enough?	5
A Modified liver donor risk index for pediatric liver transplant recipients	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	5
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant	5
A scoping review of nonmedical barriers to living donor liver transplant	5